Unclaimed Scholar Profile
Are you Frederick Johan Raal? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-2517-5543-6756 orcid.org/0000-0002-9170-7938
Frederick Johan Raal
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand, specializing in Health Sciences. [Discipline: Health Sciences]
#Lipoproteins and Cardiovascular Health#Lipid metabolism and disorders#Cholesterol and Lipid Metabolism#Diabetes#Cardiovascular Risks#and Lipoproteins
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 37,714 | 3,966 |
| h-index | 72 | 50 |
| i10-index | 210 | 126 |
Annual Citation Growth
Verified Citations / Year0
2020397
2021+40%555
2022+29%714
2023+33%952
2024-8%873
2025-45%476
2026Scholarship Distribution & Proportions517 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (30,925) • 18% Global Research Impact (6,789)
517 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (517)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Published in New England Journal of Medicine•2015
DOI: 10.1056/nejmoa1501031 Verified Peer-Reviewed
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Published in New England Journal of Medicine•2020
DOI: 10.1056/nejmoa1912387 Verified Peer-Reviewed
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Published in European Heart Journal•2020
DOI: 10.1093/eurheartj/ehz962 Verified Peer-Reviewed
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Published in New England Journal of Medicine•2015
DOI: 10.1056/nejmoa1500858 Verified Peer-Reviewed
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Published in European Heart Journal•2015
DOI: 10.1093/eurheartj/ehv043 Verified Peer-Reviewed
Showing 1 – 5 of 517 publications
1 / 104